Gunjo · Business Intelligence for the AI Era
← Sticker Wall MODEL · DETAIL

AI-Powered Pet Consultation and Medication Closed-Loop Platform

1) Online consultations: Pay-per-use or subscription-based membership; 2) Commission on medication and supplements: Reve

MODEL

Key Fields

FIELD STAMPS
IndustryPets
RegionChina
ScaleSME
ChannelOnline

📌 Background

In 2026, pet medical large models entered the stage of syndrome differentiation and treatment: Wangmiao Lingling released Baimo Mojun V4.0, increasing overall diagnostic accuracy to 92% with over 2 million platform users and a RAG semantic retrieval precision improvement of over 15% compared to the previous generation. Meanwhile, Chongzhiling has built a knowledge graph using over 68 million pet medical records, driving online consultations toward a closed-loop of evidence-based medication. Industry research indicates that China's pet economy exceeded 811.4 billion yuan in 2025, with pet healthcare leading the market at a CAGR of 22.2%.

👤 Target Customers

Pet owners and veterinary clinics; users pay for consultations, while clinics pay for AI-assisted diagnostic tools.

💰 Revenue Streams

1) Online consultations: Pay-per-use or subscription-based membership; 2) Commission on medication and supplements: Revenue share based on transaction volume; 3) System licensing: Licensing fees charged to veterinary clinics for AI-assisted diagnosis and medication recommendation systems; 4) Insurance partnerships: Fees based on collaborative projects with insurers (an opportunity with currently unquantified revenue potential).

🧮 Cost Structure

Large model training and computing power costs, veterinary expert team labor, medical knowledge base maintenance, and platform operations and customer acquisition costs.

🛡️ Moat

Big data in pet healthcare and a knowledge graph for syndrome differentiation and treatment, multi-round clinical data feedback to refine models, and a first-mover advantage in establishing a precise medication closed-loop.

🔑 Keys to Success

  • Continuously iterate the clinical accuracy of the syndrome differentiation and treatment model
  • Integrate the full chain of consultation, testing, medication, and insurance
  • Establish data and channel partnerships with leading veterinary clinics

⚠️ Risks

  • Reputational risk due to pet injury or death caused by AI misdiagnosis
  • Stricter medical data privacy and compliance reviews
  • Pricing pressure caused by subsidy wars from large platforms

🏢 Cases

  • Wangmiao Lingling
  • Chongzhiling

📊 SWOT Analysis

Strengths

  • 92% AI diagnostic accuracy supports user trust
  • One-stop closed-loop from consultation to medication increases average transaction value

Weaknesses

  • Online consultations cannot replace physical examinations such as palpation and imaging
  • Model training relies on high-quality pet medical history data, which is costly to acquire

Opportunities

  • Growing demand from pet owners for convenient consultations and medical insurance services
  • Potential to build an ecosystem of medical testing, medication, and insurance with offline clinics, chains, and insurance companies

Threats

  • Medical disputes and regulatory risks arising from misdiagnosis
  • Large platforms like JD.com squeezing vertical players with one-stop medical, testing, and pharmacy solutions